NomoCan Pharmaceuticals offers First-in-Class targeted therapies for some of the most aggressive cancers with unmet medical need. Firm's platform technology not only makes available a selective and specific diagnostic and prognostic test for early detection, but more remarkably, it introduces a highly effective monoclonal antibody (mAb) drugs for the treatment of various cancers in order to Bring Hope to patients affected by this devastating disease.?
